100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
You Searched
₹7,530
Our Recommendation
Sutinat 50 Capsule
120+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
In Treatment of Kidney cancer : Sunitibenz 50 Capsule is used to treat kidney cancer and its associated symptoms such as blood in the urine, unexplained low back pain or weight loss, fatigue, loss of appetite, etc. It stops cancer growth and prevents multiplication of cancer cells. This restricts the advancement of cancer to other unaffected regions. You need to follow your doctor�s instructions very carefully to recover.In Treatment of Gastrointestinal stromal tumour A gastrointestinal stromal tumor (GIST) is a type of tumor that occurs most commonly in the stomach or small intestine. The tumors develop into the specialized cells called interstitial cells of Cajal (ICCs). Sunitibenz 50 Capsule helps to kill the cancer cells and also stops their further growth and spread. Follow your doctor�s instructions carefully to get the most benefit. show moreshow less
Side effects of Sunitibenz Capsule The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Sunitibenz Hand-foot syndrome Bleeding disorder Low blood platelets Decreased appetite Nausea Vomiting Weakness Abdominal pain Indigestion High blood pressure Diarrhea Stomatitis (Inflammation of the mouth)Taste change
How to use Sunitibenz Capsule Follow your doctor's guidance regarding the dose and duration of this medication. Sunitibenz 50 Capsule can be taken it with or without food, although it's advisable to take it consistently at the same time.
How Sunitibenz Capsule works Sunitibenz 50 Capsule is an anti-cancer medication. It works by binding and blocking certain cell surface protein (tyrosine kinase) responsible for the propagation of cancer growth. It also restricts the growth of new blood vessels within the tumor. This is how it prevents the proliferation of malignant cancers.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Sunitibenz 50 Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Sunitibenz 50 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Sunitibenz 50 Capsule is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Sunitibenz 50 Capsule may cause side effects which could affect your ability to drive.Sunitibenz 50 Capsule may cause dizziness during the treatment. Do not drive or operate machineries if you experience this while on treatment with the medicine.
Sunitibenz 50 Capsule is safe to use in patients with kidney disease. No dose adjustment of Sunitibenz 50 Capsule is recommended.
Sunitibenz 50 Capsule is safe to use in patients with liver disease. No dose adjustment of Sunitibenz 50 Capsule is recommended.
If you forget a dose of Sunitibenz 50 Capsule , simply continue with your regular schedule and do not take a double dose.
SCO 84, Sector 5, Panchkula (Haryana), 134112 INDIA.
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1740
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 955
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1304
Sunitinib malate (25 Oct. 2023)
Sunitinib malate. Sandwich, Kent: Pfizer Limited; 2006 (27 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.